Prognostic impact of bone marrow fibrosis in primary myelofibrosis. A study of the AGIMM group on 490 patients-Reference-Cited by-同舟云学术

Prognostic impact of bone marrow fibrosis in primary myelofibrosis. A study of the AGIMM group on 490 patients

Published:2016-07-04 Issue:9 Volume:91 Page:918-922
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Guglielmelli Paola¹,Rotunno Giada¹,Pacilli Annalisa¹,Rumi Elisa²³,Rosti Vittorio⁴,Delaini Federica⁵,Maffioli Margherita⁶,Fanelli Tiziana¹⁷,Pancrazzi Alessandro¹,Pieri Lisa¹,Fjerza Rajmonda¹,Pietra Daniela²,Cilloni Daniela⁸,Sant'Antonio Emanuela¹,Salmoiraghi Silvia⁵,Passamonti Francesco⁶,Rambaldi Alessandro⁵,Barosi Giovanni⁴,Barbui Tiziano⁹,Cazzola Mario²³,Vannucchi Alessandro M.¹

Affiliation:

1. Department of Experimental and Clinical Medicine and DENOTHE Excellence Center; CRIMM-Center for Research and Innovation of Myeloproliferative Neoplasms, AOU Careggi, University of Florence; Florence Italy

2. Department of Hematology Oncology; Fondazione IRCCS Policlinico San Matteo; Pavia Italy

3. Department of Molecular Medicine; University of Pavia; Pavia Italy

4. Center for the Study of Myelofibrosis, Research Lab of Biotechnology, IRCCS Policlinico San Matteo Foundation; Pavia Italy

5. Hematology and BMT Unit; ASST Papa Giovanni XXIII; Bergamo Italy

6. Ospedale Di Circolo; Fondazione Macchi Università Degli Studi Dell'Insubria; Varese Viale Borri 57 Varese Italia

7. University of Siena; Italy

8. Department of Clinical and Biological Sciences University of Turin; San Luigi Hospital Turin; Italy

9. Research Foundation; Ospedale Papa Giovanni XXIII; Bergamo Italy

Funder

Associazione Italiana per la Ricerca sul Cancro

Ministero della Salute

Publisher

Wiley

Subject

Hematology

Reference15 articles.

1. Advances in understanding and management of myeloproliferative neoplasms;Vannucchi;CA Cancer J Clin,2009

2. European consensus on grading bone marrow fibrosis and assessment of cellularity;Thiele;Haematologica,2005

3. The 2016 revision to the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia;Arber;Blood,2016

4. Grade of bone marrow fibrosis is associated with relevant hematological findings-A clinicopathological study on 865 patients with chronic idiopathic myelofibrosis;Thiele;Ann Hematol,2006

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metastatic splenic angiosarcoma presenting with anemia and bone marrow fibrosis mimicking primary myelofibrosis: A case report and literature review;Molecular and Clinical Oncology;2024-01-04

2. Emerging Treatment Options for Myelofibrosis: Focus on Anemia;Therapeutics and Clinical Risk Management;2023-06

3. International Consensus Classification of myeloid and lymphoid neoplasms: myeloproliferative neoplasms;Virchows Archiv;2022-12-29

4. Targeted sequencing of candidate gene regions for myelofibrosis in dogs;Journal of Veterinary Internal Medicine;2022-07

5. Momelotinib for the treatment of myelofibrosis with anemia;Future Oncology;2022-06